MAP3K3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.40229996690312E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
9.92749999999543E-05 |
Normal-vs-Stage2 |
5.88219999999584E-05 |
Normal-vs-Stage3 |
1.9959001118508E-10 |
Normal-vs-Stage4 |
3.78180042837073E-10 |
Stage1-vs-Stage2 |
9.322300E-02 |
Stage1-vs-Stage3 |
3.230600E-04 |
Stage1-vs-Stage4 |
2.559400E-04 |
Stage2-vs-Stage3 |
5.056000E-01 |
Stage2-vs-Stage4 |
2.999000E-01 |
Stage3-vs-Stage4 |
6.088600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.13970005339348E-09 |
Normal-vs-AfricanAmerican |
8.604500E-02 |
Normal-vs-Asian |
6.127000E-01 |
Caucasian-vs-AfricanAmerican |
6.879900E-02 |
Caucasian-vs-Asian |
1.370390E-02 |
AfricanAmerican-vs-Asian |
3.067800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.35509994733962E-09 |
Normal-vs-Female |
1.89750000001432E-06 |
Male-vs-Female |
2.465400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.952000E-04 |
Normal-vs-Age(41-60Yrs) |
4.43900000002273E-06 |
Normal-vs-Age(61-80Yrs) |
1.4790999980363E-08 |
Normal-vs-Age(81-100Yrs) |
3.76039999999689E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.312000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.903200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.363600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.898400E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.234980E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.942600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.937900E-02 |
Normal-vs-Grade 2 |
3.51830000000497E-05 |
Normal-vs-Grade 3 |
8.91240414802041E-11 |
Normal-vs-Grade 4 |
7.61249996372726E-09 |
Grade 1-vs-Grade 2 |
4.430200E-04 |
Grade 1-vs-Grade 3 |
8.76219999890182E-08 |
Grade 1-vs-Grade 4 |
6.7547000004442E-07 |
Grade 2-vs-Grade 3 |
3.138800E-03 |
Grade 2-vs-Grade 4 |
1.079690E-02 |
Grade 3-vs-Grade 4 |
5.417400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.32680000003638E-06 |
Normal-vs-ccB subtype |
7.86339999780949E-08 |
ccA subtype-vs-ccB subtype |
2.235600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.60900000492725E-08 |
Normal-vs-N1 |
1.355410E-03 |
N0-vs-N1 |
6.015400E-01 |
|
|